Results of the VANISH-2 trial, building on prior research, further upheld superiority of catheter ablation over ...

Two novel agents targeting angiopoietin-like protein 3 demonstrated safety and lipid-lowering capabilities in phase 2 trials, ...

To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali ...

TCTMD journalists share their highlights, from a novel endovascular therapy to pacing questions, early ezetimibe, and more.

A reduction in risk factors like high blood pressure can delay cardiovascular events by 2.4 years for women and 1.2 years for ...

Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) 74th Annual Scientific Session and Expo in Chicago, March 29-31.

Recalling her first presentation at McKinsey, Aggarwal explained how a partner’s request for a single clear recommendation left her unprepared. “I had 15 recommendations, like a menu. I thought the ...

She says her eighth grader showed it to her. It's pictures from presentation slides showing what some people say depicts Musk as a Nazi and President Trump as a cult leader. "It's concerning to me ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing ...